Interaction Guide · Research summary

Can I take Melatonin with Meclizine?

Review Melatonin with Meclizine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Melatonin may add to meclizine-related sleepiness or impairment. Review the dose and formulation, particularly if you already feel drowsy; the exact combination’s risk has not been quantified.

What this answer covers

Oral meclizine with the specific preparation described below.

Supplement or preparation
Melatonin
Medication ingredient
meclizine

Sleepiness is possible with both products

Meclizine can impair alertness. Melatonin can also cause sleepiness, and its effects may last longer in some older people. That supports checking the combination against the actual dose and daily activities.

Feeling sleepy and measured performance are different

A small placebo-controlled study of afternoon melatonin found increased subjective sleepiness after a prolonged task, but no overall adverse effect on its objective driving-test battery. This does not mean every melatonin dose causes measurable impairment.

No exact combination estimate was established

The driving experiment did not include meclizine. It cannot provide a combined event rate, prove increased medicine concentrations or validate a short dosing gap. Other medicines, alcohol and sleep deprivation can also affect the practical assessment.

Review the whole alertness burden

Bring the exact supplement label and all medicines to your pharmacist, particularly if meclizine already makes you sleepy, dizzy or confused. Avoid driving when affected. The reviewed evidence does not identify a supplement dose or hours-apart schedule that guarantees normal alertness.

Evidence and practical considerations

Side effects & toxicity

Melatonin may add to meclizine-related sleepiness or impairment. Review the dose and formulation, particularly if you already feel drowsy; the exact combination’s risk has not been quantified.

Exact scope
Oral meclizine with the specific preparation described below. with Oral meclizine; the hyoscine source, where relevant, is explicitly transdermal.
Medication form and route
oral

What remains uncertain

  • Conditional alertness precaution from exact medication and melatonin effects. Original melatonin objective-performance null retained; no exact co-use incidence, PK change or respiratory-depression estimate.

Factors that may matter: Exact preparation and amount; Other medicines with overlapping effects; Route and gut-transit status where relevant.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: Current U.S. regulatory product labeling

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral meclizine.

Meclizine may cause drowsiness; alcohol and other CNS depressants may increase impairment. The label discusses possible CYP2D6 inhibitor effects but does not establish a named botanical interaction.

How this applies: Exact active ingredient and oral-route context.

Label warnings do not measure every exact supplement pair or provide a universal safe supplement dose or interval.

Source 2: Federal supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering the named botanical or supplement.

Sleepiness is a possible effect. Older people may have prolonged daytime drowsiness; commercial products and long-term safety data vary.

How this applies: Supports conditional alertness review without claiming every dose objectively impairs performance.

General guidance does not quantify this exact medication combination or establish a universal protective interval.

Source 3: Original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Twenty healthy adults in a crossover.

Subjective sleepiness increased after a prolonged task, but the overall objective driving-test battery did not show impairment.

How this applies: Supports nuance between sleepiness and measured performance.

Small, single-dose study, no meclizine, carbinoxamine or promethazine co-use.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Initial source-checked research draft with exact preparation limits, contrary findings and source-access details. Clinical review not recorded.
Research summary published

Article revision: 2d4d084847d12fe6

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.